KWM
TMDX icon

Keebeck Wealth Management’s Transmedics TMDX Stock Holding History

Keebeck Wealth Management’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$387K Buy
5,820
+645
+12% +$54.6K 0.04% 313
2026
Q1 		$514K Buy
5,175
+572
+12% +$74.6K 0.06% 230
2025
Q4 		$560K Buy
4,603
+1,768
+62% +$222K 0.06% 203
2025
Q3 		$318K Buy
+2,835
New +$332K 0.04% 294

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Keebeck Wealth Management's TMDX Position: Q2 2026 in Review

Keebeck Wealth Management increased its Transmedics (TMDX) stake by 12% in Q2 2026, buying an estimated $54.6K and bringing the position to 5,820 shares worth $387K. The position accounts for 0.04% of the portfolio, ranked #313.

Keebeck Wealth Management first reported a position in TMDX in Q3 2025 and has held it in 4 quarters since. The position peaked at $560K in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Keebeck Wealth Management held 5,820 shares of Transmedics worth $387K as of Q2 2026.
  • Keebeck Wealth Management bought 645 Transmedics shares in Q2 2026, an estimated $54.6K.
  • Transmedics made up 0.04% of Keebeck Wealth Management's portfolio in Q2 2026, its #313 holding.
  • Keebeck Wealth Management first reported a position in Transmedics in Q3 2025 and has held it in 4 quarters since.
  • Keebeck Wealth Management's Transmedics position peaked at $560K in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Keebeck Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.